The Trump approach to the economy is anything but conservative, write Yale SOM’s Jeffrey Sonnenfeld, former Procter & Gamble ...

Medtronic shows mixed results with strong Cardiovascular growth and weaker Neuroscience/MedSurg. Click here to read an ...

The FDA updated its list of breakthrough devices as medtech groups lobby for faster Medicare coverage of products with the designation.

Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic ...

The use of robotics in surgery is on the rise. The market was valued at $800 million in 2015, and has since risen to over $3 ...

Citi analyst Joanne Wuensch raised the firm’s price target on Medtronic (MDT) to $101 from $99 and keeps a Buy rating on the shares. The firm ...